Lymphokine-activated Killer Cells in Rats: Analysis of Tissue and Strain Distribution, Ontogeny, and Target Specificity1 (original) (raw)
In vivo distribution and tissue localization of highly purified rat lymphokine-activated killer (LAK) cells
Nikola Vujanovic
Cellular Immunology, 1988
View PDFchevron_right
Lymphokine-activated killer cells in rats: Generation of natural killer cells and lymphokine-activated killer cells from bone marrow progenitor cells
Nikola Vujanovic
Cellular Immunology, 1989
View PDFchevron_right
Generation of human lymphokine-activated killer cells following brief exposure to high dose interleukin 2
John Yannelli
Cancer research, 1990
View PDFchevron_right
Both the precursors and the effectors of human lymphokine-activated killer (LAK) cells may belong to T lymphocytes
Alessandro Poggi
La Ricerca in clinica e in laboratorio
View PDFchevron_right
Addition of interleukin-2in vitro augments detection of lymphokine-activated killer activity generatedin vivo
Jacquelyn Hank
Cancer Immunology Immunotherapy, 1990
View PDFchevron_right
Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells
Nikola Vujanovic
Journal of Experimental Medicine, 1988
View PDFchevron_right
Biodistribution of lymphokine-activated killer (LAK) cells in WAG rats after hepatic-artery or jugular-vein infusion
Gert Fleuren, Andreas Marinelli
International Journal of Cancer, 1992
View PDFchevron_right
Functional studies on the precursors of human lymphokine-activated killer cells
Sidney Golub
Cellular Immunology, 1985
View PDFchevron_right
Exogenous interleukin 2 recruits in vitro lymphokine-activated killer activity by in vivo activated lymphocytes
Prof.dr.REINDER LH BOLHUIS
Cancer research, 1991
View PDFchevron_right
In vivo administration of low-dose human interleukin-2 induces lymphokine-activated killer cells for enhanced cytolysis in vitro
Marijke Bleumink
Cellular Immunology, 1991
View PDFchevron_right
KILLER CELLS IN RATS III.A Simple Method forthe Purificationof Large Granular Lymphocytes and Their Rapid Expansion and Conversion into Lymphokine-activated KillerCells
Nikola Vujanovic
2000
View PDFchevron_right
Lymphokine-activated killer (LAK) cells modulate the effects of IL-2 on a T cell-mediated immune response
Yahya Zaloom
Clinical & Experimental Immunology, 2008
View PDFchevron_right
Immunoregulation of lymphokine-activated killer cells
Stanley Schwartz
Clinical Immunology and Immunopathology, 1988
View PDFchevron_right
Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2
Yael Kaufmann
Cancer research, 1984
View PDFchevron_right
Lymphokine activated killer cells
Roland Mertelsmann
Blut, 1989
View PDFchevron_right
The generation of human lymphokine-activated killer cells in various serum-free media
John Yannelli
Journal of Immunological Methods, 1988
View PDFchevron_right
An improved method for the generation of human lymphokine activated killer cells
John Yannelli
Journal of Immunological Methods, 1987
View PDFchevron_right
Induction of lymphokine-activated killer activity in rat splenocyte cultures: The importance of 2-mercaptoethanol and indomethacin
Emile Heer
Cancer Immunology Immunotherapy, 1991
View PDFchevron_right
Morphologic analysis of human lymphokine-activated killer (LAK) cells
Peter Groscurth
International Journal of Cancer, 1990
View PDFchevron_right
Surface markers of human lymphokine-activated killer cells and their precursors. Analysis at the population and clonal level
Giuseppe Pantaleo
International Journal of Cancer, 1987
View PDFchevron_right
Inhibition of murine lymphokine-activated killer (LAK) cell activity by adherent cells
Ross Longley
Cellular Immunology, 1989
View PDFchevron_right
Lymphokine-activated killer (LAK) cells. Analysis of factors relevant to the immunotherapy of human cancer
Anthony Rayner
Cancer, 1985
View PDFchevron_right
IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures
Robert Kastelein
Journal of Immunology, 1988
View PDFchevron_right
Studies of serum-free medium for the generation of lymphokine-activated killer cells
Kosei Yasumoto
Cytotechnology, 1991
View PDFchevron_right
Immunomodulatory effects of systemic low-dose recombinant interleukin-2 and lymphokine-activated killer cells in humans
John Mannick
Cancer Immunology Immunotherapy, 1989
View PDFchevron_right
Natural killer cell activity in the rat. VI. Characterization of rat large granular lymphocytes as effector cells in natural killer and antibody-dependent cellular cytotoxic activities
William R Overton
Journal of leukocyte biology, 1987
View PDFchevron_right
AUGMENTATION OF ORGAN-ASSOCIATED NATURAL KILLER ACTIVITY BY BIOLOGICAL RESPONSE MODIFIERS Isolation and Characterization of Large Granular Lymphocytes from the Liver
James Talmadge
View PDFchevron_right
Lymphokine-activated killer (LAK) cells: I Interferon-γ synergizes with interleukin-2 to induce LAK cytotoxicity in homogeneous leukemic preparations
Yael Kaufmann
Clinical Immunology and Immunopathology, 1991
View PDFchevron_right
Interleukin-2-dependent long-term cultures of low-density lymphocytes allow the proliferation of lymphokine-activated killer cells with natural killer, Tiγ/δ or TNK phenotype
ugo testa
Cancer Immunology Immunotherapy, 1990
View PDFchevron_right
Augmentation of mouse liver-associated natural killer activity by biologic response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrow
James E Talmadge
The Journal of Immunology
View PDFchevron_right
Generation of natural killer cells and lymphokine-activated killer cells in human AB serum or fetal bovine serum
Turgut Imir
Clinical Immunology and Immunopathology, 1985
View PDFchevron_right
Interleukin-6 enhances the induction of human lymphokine-activated killer cells
Farook Al-azzawi
Cancer Immunology Immunotherapy, 1990
View PDFchevron_right
MONOCLONAL ANTIBODY TO A TRIGGERING STRUCTURE EXPRESSED ON RAT NATURAL KILLER CELLS AND ADHERENT LYMPHOKINE-ACTIVATED KILLER CELLS
Nikola Vujanovic
2000
View PDFchevron_right
Human recombinant interleukin-4 inhibits lymphokine-activated killer activity of sheep erythrocyte rosette-forming (E+) and -non-forming (E−) human lymphocytes
Massimo Gerosa
International Journal of Cancer, 1988
View PDFchevron_right
The proliferation and life-span of rat large granular lymphocytes: effects of cytokines
Sigbjørn Fossum
European Journal of Immunology, 1989
View PDFchevron_right